Cynthia Firnhaber to Cost-Benefit Analysis
This is a "connection" page, showing publications Cynthia Firnhaber has written about Cost-Benefit Analysis.
Connection Strength
0,686
-
Cost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis. BMC Health Serv Res. 2015 Nov 06; 15:499.
Score: 0,449
-
Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):195-205.
Score: 0,137
-
Impact of adverse drug reactions on the incremental cost-effectiveness of bedaquiline for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2018 08 01; 22(8):918-925.
Score: 0,034
-
Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa. Int J Tuberc Lung Dis. 2018 04 01; 22(4):393-398.
Score: 0,033
-
Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis. Appl Health Econ Health Policy. 2018 Feb; 16(1):43-54.
Score: 0,033